Latest Market News

QMines Limited’s maiden drilling program at Mount Mackenzie delivers consistent high-grade gold and silver results, confirming multiple mineralised zones with promising depth extensions. The company advances towards an updated Pre-Feasibility Study, underpinning future mine design and resource growth.

Legacy Minerals has initiated a 2,000-metre diamond drilling program at the Mascotte Silver-Gold Prospect, aiming to grow its substantial 115Moz silver-equivalent resource at Mt Carrington. This move follows promising historical data and recent rock chip assays confirming high-grade gold and silver mineralisation.

PWR Holdings has secured a US$9.1 million follow-on contract to supply advanced cooling solutions for a US government aerospace and defence project, extending its involvement through FY 2027.

Venus Metals Corporation has issued a second supplementary target’s statement urging shareholders to reject QGold’s increased takeover offer of $0.21 per share, citing significant undervaluation of its key assets and improved financial position.

Far East Gold has confirmed a 50-metre lateral extension of high-grade gold mineralisation at its Idenburg Project in Papua, Indonesia, with assay results from drillhole KSD027 revealing bonanza-grade intervals up to 175 g/t Au. This marks the fifth consecutive drillhole confirming robust gold zones, underpinning the prospect’s significant growth potential.

BluGlass and North Carolina State University have secured a third-year contract extension worth A$1.05 million from the U.S. Department of War’s CLAWS Hub, reinforcing their role in advanced gallium nitride laser development for defence and quantum technologies.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.

Super Retail Group has reported a record 13.1% sales growth in the first half of FY26, with normalised profit before tax expected between $172 million and $175 million despite margin challenges and weather impacts.

Regal Partners anticipates a strong 2025 with normalised NPAT reaching $145 million, propelled by a significant jump in performance fees and funds under management climbing to $20.8 billion.

EBR Systems reported a doubling of WiSE System implants in Q4 FY2025 alongside the launch of key clinical studies and preliminary revenue guidance, signalling strong commercial and clinical momentum.

Cyclopharm secures a landmark deal with Lucile Packard Children’s Hospital Stanford to introduce Technegas, marking the first dedicated children’s hospital in the US to adopt this advanced lung imaging technology.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its Vision-MR Diagnostic Catheter, paving the way for commercial sales in the US electrophysiology market.